<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0002005875</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001719714</issuerCik>
<issuerName>Mereo BioPharma Group plc</issuerName>
<secFileNumber>001-38452</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">4th Floor, One Cavendish Place</street1>
<city xmlns="http://www.sec.gov/edgar/common">London</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">W1G 0QF</zipCode>
</issuerAddress>
<issuerContactPhone>44-333 023 7300</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Alexandra Hughes-Wilson</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>American Depositary Shares Representing Ordinary Shares</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">38th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>100432</noOfUnitsSold>
<aggregateMarketValue>297505.97</aggregateMarketValue>
<noOfUnitsOutstanding>702493754</noOfUnitsOutstanding>
<approxSaleDate>05/22/2024</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>American Depositary Shares Representing Ordinary Shares</securitiesClassTitle>
<acquiredDate>05/22/2024</acquiredDate>
<natureOfAcquisitionTransaction>Share Option Exercise</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>50350</amountOfSecuritiesAcquired>
<paymentDate>05/22/2024</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>American Depositary Shares Representing Ordinary Shares</securitiesClassTitle>
<acquiredDate>05/22/2024</acquiredDate>
<natureOfAcquisitionTransaction>Share Option Exercise</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>50082</amountOfSecuritiesAcquired>
<paymentDate>05/22/2024</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>The number of shares to be sold is in the form of American Depositary Shares ("ADSs"). The number of shares outstanding is in the form of ordinary shares.

Each ADS represents 5 ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.</remarks>
<noticeSignature>
<noticeDate>05/23/2024</noticeDate>
<signature>/s/ Alexandra Hughes-Wilson</signature>
</noticeSignature>
</formData>
</edgarSubmission>
